Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Re-post Dr. Robert Stern from @bu_cte will be

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
(Total Views: 478)
Posted On: 04/05/2022 2:13:28 AM
Avatar
Posted By: Mauibound
Re-post


Dr. Robert Stern from @bu_cte will be joining us on Thursday, April 7. We welcome everyone to RSVP for our virtual discussion on what we know about the long-term consequences of #CTE. Learn more and RSVP at
https://concussion.umich.edu/event/concussion...stern-phd/

Chronic Traumatic Encephalopathy (CTE) and the Long-Term Consequences of Sports-Related Repetitive Head Impact Exposure: What We Know Now and What We Need to Know NextThursday, April 7
4:00-5:00pm
via Zoom
featuring

Dr. Robert A. Stern, PhDProfessor of Neurology, Neurosurgery, and Anatomy & Neurobiology
Co-Founder and Director of Clinical Research, BU CTE Center
Senior Investigator, BU Alzheimer’s Disease Research Center
Boston University School of Medicine

 

Dr. Robert Stern will present the neuropathological features of chronic traumatic encephalopathy (CTE), including what is currently known about risk factors for developing CTE; the clinical features associated with CTE and the NINDS Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome; and the possible fluid and neuroimaging biomarkers for CTE.

Dr. Robert Stern is a Professor of Neurology, Neurosurgery, and Anatomy & Neurobiology at Boston University (BU) School of Medicine. Dr. Stern has been a clinician, researcher, and lecturer in the area of Alzheimer’s disease and related disorders for over 30 years. From 2010-2019 he was Clinical Core Director of the NIH-funded BU Alzheimer’s Disease Research Center (BU ADRC) and is currently Senior Scientist for the BU ADRC. He oversees several clinical trials for the treatment and prevention of Alzheimer’s and has conducted research on innovative new tests to detect and diagnose the disease. Dr. Stern is an internationally recognized expert on chronic traumatic encephalopathy (CTE) and the long-term effects of repetitive head impacts in athletes. He is Co-Founder and Director of Clinical Research for the BU CTE Center, and he is the lead investigator of a $17 million, 7-year NIH grant for a multi-center study to develop methods of diagnosing CTE during life as well as examining potential risk factors of the disease. Dr. Stern has over 250 publications, is a member of several medical journal editorial boards, and is the co-editor of two textbooks: Sports Neurology (Dr. Brian Hainline, co-editor), part of the Handbook of Clinical Neurology series, and the Oxford Handbook of Adult Cognitive Disorders (Dr. Michael Alosco, co-editor). He is a clinical neuropsychologist and has developed several widely used neuropsychological tests, including the Neuropsychological Assessment Battery (NAB). He is a Fellow of the American Neuropsychiatric Association and the National Academy of Neuropsychology.

CME Credits

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EBP Credits

University of Michigan Athletic Department (BOC AP# P8320) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. This program is eligible for a maximum of 1 EBP Category hours/CEUs. ATs should claim only those hours actually spent in the educational program.

REGISTER FOR EVENT

 

Date And Time

Apr-07-22 @ 04:00 PM (EDT) to
Apr-07-22 @ 05:00 PM (EDT)



(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us